Cardiac Rhythm Management Devices Market to Aggregate USD 35.20 Billion by 2026
The global Cardiac Rhythm Management Devices market in 2019 was approximately USD 21.11 Billion. The market is expected to grow at a CAGR of 7.5% and is anticipated to reach around USD 35.20 Billion by 2026.
Cardiac rhythm management (CRM) devices monitor’ heartbeats. Such devices are vital for the treatment of severe cardiac conditions, including atrial flutter, atrial fibrillation, heart failure, coronary ischemia, recent heart attack symptoms, lack of oxygen supply to cardiac muscles, and certain genetic defects among others. These devices assist in repairing, restoring, and healing cardiac activities.
Get a Copy of Free Sample Report Here
The cardiac rhythm management devices market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entire cardiac rhythm management devices market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of both volumes (Units) and value (USD Million) from FY 2016 – 2026.
Key Segments: Cardiac Rhythm Management Devices Market
The cardiac rhythm management devices market is segmented based on product and end-user. On the basis of product segmentation, the market is classified into pacemakers, defibrillators, and Cardiac Resynchronization Therapy (CRT). Furthermore, pacemakers are sub-segmented implantable and external. The defibrillators are divided into Implantable Cardioverter Defibrillators (ICD) and external defibrillators. The Implantable Cardioverter Defibrillators (ICD) are classified into subcutaneous ICD (S-ICD) and transvenous ICD (T-ICD).
Inquire more before buying this report Here
Major Market Players
Top players operating in the cardiac rhythm management devices market, but not restricted to include Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, GE Healthcare, Biotronik Inc., ZOLL Medical Corporation, Schriller AG, Koninklijke Philips N.V., Nihon Kohden Corporation, and Hill-Rom Holdings amongst others.